Tirzepatide and the risk of atrial fibrillation: an updated meta-analysis of randomized controlled trials

29 August 2025 (07:00 - 18:00)
Organised by: Logo
Congress Presentation Part of: Diabetes and the heart (3) Pharmacotherapy ESC Professional Premium Access ESC Congress 2025 European Society of Cardiology

ESC 365 is supported by

ESC 365 is supported by